Angiotensin Converting Enzyme Inhibitor and HMG-CoA Reductase Inhibitor as Adjunct Treatment for Persons with HIV Infection: A Feasibility Randomized Trial

BACKGROUND: Treatments that reduce inflammation and cardiovascular disease (CVD) risk among individuals with HIV infection receiving effective antiretroviral therapy (ART) are needed. DESIGN AND METHODS: We conducted a 2×2 factorial feasibility study of lisinopril (L) (10 mg daily) vs L-placebo in c...

Descripción completa

Detalles Bibliográficos
Autores principales: Baker, Jason V., Huppler Hullsiek, Kathleen, Prosser, Rachel, Duprez, Daniel, Grimm, Richard, Tracy, Russell P., Rhame, Frank, Henry, Keith, Neaton, James D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3474775/
https://www.ncbi.nlm.nih.gov/pubmed/23082133
http://dx.doi.org/10.1371/journal.pone.0046894

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3474775/
https://www.ncbi.nlm.nih.gov/pubmed/23082133
http://dx.doi.org/10.1371/journal.pone.0046894

Ejemplares similares